Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Non-Current Debt: 2024

Historic Non-Current Debt for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $6.9 million.

  • Kura Oncology's Non-Current Debt fell 31.21% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 31.21%. This contributed to the annual value of $6.9 million for FY2024, which is N/A change from last year.
  • As of FY2024, Kura Oncology's Non-Current Debt stood at $6.9 million.
  • Kura Oncology's 5-year Non-Current Debt high stood at $6.9 million for FY2024, and its period low was $6.9 million during FY2024.
  • Moreover, its 1-year median value for Non-Current Debt was $6.9 million (2024), whereas its average is $6.9 million.